Targetable pathogenic mechanisms in nasal polyposis

Alexander L Schneider1, Robert P Schleimer1,2, Bruce K Tan1,2

  • 1Department of Otolaryngology, Head and Neck Surgery, Chicago, Illinois, USA.

Insights

Chronic rhinosinusitis with nasal polyps (CRSwNP) is a complex condition. This review explores new targeted therapies beyond type 2 inflammation for CRSwNP, examining ongoing clinical studies.

Area of Science:

  • Immunology
  • Otolaryngology
  • Pharmacology

Background:

  • Chronic rhinosinusitis with nasal polyps (CRSwNP) frequently recurs despite treatment.
  • Current CRSwNP biologics target type 2 inflammation, but other pathways may be involved.

Purpose of the Study:

  • To review pathogenic mechanisms in CRSwNP.
  • To discuss ongoing clinical trials of targeted therapeutics for CRSwNP.

Main Methods:

  • Literature review of CRSwNP pathophysiology.
  • Analysis of ongoing clinical studies for targeted therapies.
  • Exploration of therapeutic targets in related inflammatory diseases.

Main Results:

  • Type 2 inflammation is a primary target of current CRSwNP biologics.
  • Other inflammatory pathways in CRSwNP warrant investigation for targeted therapies.
  • Clinical trials are evaluating novel targeted agents for CRSwNP.

Conclusions:

  • Understanding diverse CRSwNP pathogenic mechanisms is crucial.
  • Targeted therapeutics beyond type 2 inflammation hold promise for CRSwNP treatment.
  • Further research into non-type 2 pathways may yield new therapeutic options.

Related Concept Videos

Cystic Fibrosis: Pathogenesis01:23

Cystic Fibrosis: Pathogenesis

Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
542
Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
3.7K
Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
958
Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors01:24

Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors

Peptic ulcer disease, commonly called PUD, represents a multifaceted condition characterized by disruptions in the lining of the gastrointestinal (GI)  tract. Central to the protection of the gastrointestinal lining is the mucosal-bicarbonate barrier. This physiological defense mechanism is a formidable shield against the corrosive effects of gastric acid and pepsin secretion in the stomach. Its role is pivotal in maintaining the structural integrity of the stomach's inner lining.
851
Single Nucleotide Polymorphisms-SNPs01:05

Single Nucleotide Polymorphisms-SNPs

A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
17.3K
Asthma-II: Pathophysiology and Classification01:26

Asthma-II: Pathophysiology and Classification

Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
3.6K